Health Sciences Acquisitions Corp 2 extends SPAC deadline to Jan 6, 2023

Orchestra BioMed Holdings, Inc.

Board elected to extend business combination deadline from Nov 6, 2022 to Jan 6, 2023.
Extension is the first of up to three monthly extensions allowed by shareholder-approved amendment.
If no business combination by Jan 6, 2023, Company must redeem shares and dissolve.

item 3.03

Orchestra BioMed Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-073189

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.